Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Ambrisentan plus spironolactone
(D00443)
[1] Ambrisentan[1] Ambrisentan 💬 [1] EDNRA 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
2Spironolactone
(D00443)
[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[7] 46, 58, 67, 86, 113, 210, 225 💬
3Spironolactone and conivaptan
(D00443)
[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 86 💬
4Spironolactone mylan 25 MG comprimé pelliculé Sécable
(D00443)
[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 46 💬
5Spironolactone or finerenone
(D00443)
[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 218 💬